References - Therapeutic Strategies in Cancer Biology and Pathology - page 251

Tanaka, T., Arai, M., Wu, S., Kanda, T., Miyauchi, H., Imazeki, F., et al., 2011. Epigenetic
silencing of microRNA-373 plays an important role in regulating cell proliferation in
colon cancer. Oncol. Rep. 26, 1329-1335.
Tanaka, Y., Kato, K., Mibu, R., Uchida, S., Asanoma, K., Suzuki, K., et al., 2008.
Medroxyprogesterone acetate inhibits proliferation of colon cancer cell lines by modulat-
ing cell cycle-related protein expression. Menopause-J. North Am. Menopause. Soc. 15,
442-453.
Tang, H., Park, S., Sun, S.C., Trumbly, R., Ren, G., Tsung, E., et al., 2010. RKIP inhibits
NF-kappa B in cancer cells by regulating upstream signaling components of I kappa B
kinase complex. FEBS Lett. 584, 662-668.
Tang, J.T., Wang, J.L., Du, W., Hong, J., Zhao, S.L., Wang, Y.C., et al., 2011a. MicroRNA
345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in
human colorectal cancer. Carcinogenesis 32, 1207-1215.
Tang, Q.L., Zhao, Z.Q., Li, J.C., Liang, Y., Yin, J.Q., Zou, C.Y., et al., 2011b. Salinomycin
inhibits osteosarcoma by targeting its tumor stem cell. Cancer Lett. 311, 113-121.
Tang, T., Tang, J.Y., Li, D., Reich, M., Callahan, C.A., Fu, L., et al., 2011c. Targeting superfi-
cial or nodular basal cell carcinoma with topically formulated small molecule inhibitor of
Smoothened. Clin. Cancer Res. 17, 3378-3387.
Taniguchi, H., Horinaka, M., Yoshida, T., Yano, K., Goda, A.E., Yasuda, S., et al., 2012.
Targeting the glyoxalase pathway enhances TRAIL efficacy in cancer cells by downregu-
lating the expression of antiapoptotic molecules. Mol. Cancer Ther. 11, 2294-2300.
Tao, J., Lu, Q., Wu, D., Li, P., Xu, B., Qing, W., et al., 2011. microRNA-21 modulates cell prolif-
eration and sensitivity to doxorubicin in bladder cancer cells. Oncol. Rep. 25, 1721-1729.
Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., et al., 2007.
Differential regulation of microRNAs by p53 revealed by massively parallel sequencing -
miR-34a is a p53 target that induces apoptosis and G(1)-arrest. Cell Cycle 6, 1586-1593.
Tatton, L., Morley, G.M., Chopra, R., Khwaja, A., 2003. The Src-selective kinase inhibitor
also inhibits Kit and Bcr-Abl tyrosine kinases. J. Biol. Chem. 278, 4847-4853.
Tawbi, H.A., Rodon Ahnert, J., Dummer, R., Thomas, A.L., Granvil, C., Shou, Y., et al. 2011.
Phase I study of LED225 in advanced solid tumours: updated analysis of safety, prelimi-
nary efficacy, pharmacokinetic-pharmacodynamic correlation. J. Clin. Oncol. 29, 3062.
Teng, I.W., Hou, P.C., Lee, K.D., Chu, P.Y., Yeh, K.T., Jin, V.X., et al., 2011. Targeted meth-
ylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells
into cancer stem/initiating cells. Cancer Res. 71, 4653-4663.
Thaler, S., Haehnel, P.S., Schad, A., Dammann, R., Schuler, M., 2009. RASSF1A mediates
p21(Cip1/Waf1)-dependent cell cycle arrest and senescence through modulation of the
Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res. 69, 1748-1757.
Thomas, Z.I., Gibson, W., Sexton, J.Z.K., Aird, K.M.L., Ingram, S.M., Aldrich, A., et al.,
2011. Targeting GLI1 expression in human inflammatory breast cancer cells enhances
apoptosis and attenuates migration. Br. J. Cancer 104, 1575-1586.
Thoren, K.L., Krantz, B.A., 2011. The unfolding story of anthrax toxin translocation. Mol.
Microbiol. 80, 588-595.
Tiainen, M., Vaahtomeri, K., Ylikorkala, A., Makela, T.P., 2002. Growth arrest by the LKB1
tumor suppressor: Induction of p21(WAF1/CIP1). Human Mol. Genet. 11, 1497-1504.
Tison, B.E., Nicholas, S.K., Abramson, S.L., Hanson, I.C., Paul, M.E., Seeborg, F.O., et al.,
2011. Autoimmunity in a cohort of 130 pediatric patients with partial DiGeorge syn-
drome. J. Allergy Clin. Immunol. 128, 1115-1117.
Tivnan, A., Tracey, L., Buckley, P.G., Alcock, L.C., Davidoff, A.M., Stallings, R.L., 2011.
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma. BMC
Cancer 11, 33.